Bnc Korea Inc
256840
Company Profile
Business description
Bnc Korea Inc is engaged in research and development of application products for use in medical devices, pharmaceuticals, and cosmeceuticals. Its activities involve processing biomaterials such as hyaluronic acid and collagen to develop products containing physiologically active substances.
Contact
62 Seongseogongdan-ro 11-gil, Dalseo-gu
Room 405, Building 1, Venture Factory
Daegu Techno Park
Daegu42713
KORT: +82 7071160059
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
287
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,408.00 | 29.40 | -0.31% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,793.46 | 125.43 | 0.49% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,840.20 | 1,233.49 | 1.88% |
| NZX 50 Index | 13,838.17 | 14.04 | 0.10% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,216.90 | 32.70 | -0.35% |
| SSE Composite Index | 3,945.89 | 5.85 | 0.15% |